¾ÏÄ¡·á °ü·Ã Á¶»çº¸°í¼¿¡¼´Â ±âÁ¸ ¶Ç´Â ½Å±Ô ¾ÏÁø´Ü ¹× Ä¡·á ¹æ¹ý¿¡ °üÇÑ »ó¼¼ÇÑ Á¤º¸¸¦ Á¦°øÇÏ°í ÀÖ½À´Ï´Ù. ¶Ç ÀǾàÇ° °³¹ß ÆÄÀÌÇÁ¶óÀÎ ¹× ƯÇã ½ÇÈ¿, »ç¾÷ Á¦ÈÞ, »õ·Î¿î Ä¡·á ¹æ½Ä, Ä¡·á Åø µîÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâ·Â¿¡ ´ëÇØ ºÐ¼®ÇßÀ¸¸ç, 500°Ç ÀÌ»óÀÇ º¸°í¼¸¦ ±¸ºñÇÏ°í ÀÖ½À´Ï´Ù.
¼¼°èÀÇ Á¾¾çÇÐ ÀÓ»ó½ÃÇè ½ÃÀå
Oncology Clinical Trials
¹ßÇà 2024³â 09¿ù
°¡°Ý
US $ 5,600
£Ü 7,511,000 (ºÎ°¡¼¼ º°µµ)
|
¼¼°èÀÇ °ñ¾Ï Ä¡·á ½ÃÀå
Bone Cancer Treatment
¹ßÇà 2024³â 09¿ù
°¡°Ý
US $ 5,600
£Ü 7,511,000 (ºÎ°¡¼¼ º°µµ)
|
¼¼°èÀÇ ÀÚ±Ã¾Ï Ä¡·á ¹× Áø´Ü ½ÃÀå
Uterine Cancer Therapeutics and Diagnostics
¹ßÇà 2024³â 09¿ù
°¡°Ý
US $ 5,450
£Ü 7,310,000 (ºÎ°¡¼¼ º°µµ)
|
¼¼°èÀÇ ÆÐÇ÷¼º Àεο° Ä¡·á ½ÃÀå º¸°í¼(2024³â)
Strep Throat Treatment Global Market Report 2024
¹ßÇà 2024³â 09¿ù
°¡°Ý
US $ 5,000
£Ü 6,706,000 (ºÎ°¡¼¼ º°µµ)
|
¼¼°èÀÇ mRNA ¾Ï¹é½Å ¹× Ä¡·á ½ÃÀå º¸°í¼(2024³â)
mRNA Cancer Vaccines And Therapeutics Global Market Report 2024
¹ßÇà 2024³â 09¿ù
°¡°Ý
US $ 5,000
£Ü 6,706,000 (ºÎ°¡¼¼ º°µµ)
|
¼¼°èÀÇ ¼øȯÁ¾¾ç¼¼Æ÷(CTC) ½ÃÀå(2024-2031³â)
Global Circulating Tumor Cells (CTC) Market - 2024-2031
¹ßÇà 2024³â 08¿ù
°¡°Ý
US $ 4,350
£Ü 5,834,000 (ºÎ°¡¼¼ º°µµ)
|
¼¼°èÀÇ ±¸°¾Ï ½ÃÀå(2024-2031³â)
Global Oral Cavity Cancer Market - 2024-2031
¹ßÇà 2024³â 08¿ù
°¡°Ý
US $ 4,350
£Ü 5,834,000 (ºÎ°¡¼¼ º°µµ)
|
¼¼°èÀÇ Á¾¾ç¿ëÇؼº ¹ÙÀÌ·¯½º ¿ä¹ý ½ÃÀå(2024-2031³â)
Global Oncolytic Virus Therapy Market - 2024-2031
¹ßÇà 2024³â 08¿ù
°¡°Ý
US $ 4,350
£Ü 5,834,000 (ºÎ°¡¼¼ º°µµ)
|
¼¼°èÀÇ Ç÷°ü¸é¿ª¸ð¼¼Æ÷¼º T¼¼Æ÷ ¸²ÇÁÁ¾ ½ÃÀå(2024-2031³â)
Global Angioimmunoblastic T-Cell Lymphoma Market - 2024-2031
¹ßÇà 2024³â 08¿ù
°¡°Ý
US $ 4,350
£Ü 5,834,000 (ºÎ°¡¼¼ º°µµ)
|
¼¼°èÀÇ Á¶Á÷ÇÐ ¹× ¼¼Æ÷ÇÐ ½ÃÀå º¸°í¼(2024³â)
Histology And Cytology Global Market Report 2024
¹ßÇà 2024³â 08¿ù
°¡°Ý
US $ 5,000
£Ü 6,706,000 (ºÎ°¡¼¼ º°µµ)
|
¼¼°èÀÇ ´ã°ü¾Ï Ä¡·áÁ¦ ½ÃÀå
Cholangiocarcinoma Therapeutics
¹ßÇà 2024³â 08¿ù
°¡°Ý
US $ 5,450
£Ü 7,310,000 (ºÎ°¡¼¼ º°µµ)
|
¼¼°èÀÇ ½Å°æ³»ºÐºñÁ¾¾ç Ä¡·áÁ¦ ½ÃÀå
Neuroendocrine Tumors Therapeutics
¹ßÇà 2024³â 08¿ù
°¡°Ý
US $ 5,600
£Ü 7,511,000 (ºÎ°¡¼¼ º°µµ)
|
¼¼°èÀÇ NTRK À¶ÇÕ À¯ÀüÀÚ ¾ç¼º ÁøÇ༺ °íÇü¾Ï ½ÃÀå
NTRK Fusion Gene Positive Advanced Solid Tumors
¹ßÇà 2024³â 08¿ù
°¡°Ý
US $ 5,450
£Ü 7,310,000 (ºÎ°¡¼¼ º°µµ)
|
¼¼°è ±¸°¾Ï Ä¡·á ½ÃÀå
Oral Cancer Treatment
¹ßÇà 2024³â 08¿ù
°¡°Ý
US $ 5,450
£Ü 7,310,000 (ºÎ°¡¼¼ º°µµ)
|
¼¼°èÀÇ °íȯ¾Ï Ä¡·áÁ¦ ½ÃÀå
Testicular Cancer Drugs
¹ßÇà 2024³â 08¿ù
°¡°Ý
US $ 5,450
£Ü 7,310,000 (ºÎ°¡¼¼ º°µµ)
|
¼¼°èÀÇ ¾Ï Ä¡·á : ½ÃÀå Á¡À¯À² ºÐ¼®, »ê¾÷ µ¿Çâ ¹× Åë°è, ¼ºÀå µ¿Çâ ¿¹Ãø(2024-2029³â)
Global Cancer Therapy - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029)
¹ßÇà 2024³â 08¿ù
°¡°Ý
US $ 4,750
£Ü 6,371,000 (ºÎ°¡¼¼ º°µµ)
|
¼¼°è ½Å°æ ±³Á¾ Ä¡·á ½ÃÀå
Glioma Treatment
¹ßÇà 2024³â 08¿ù
°¡°Ý
US $ 5,450
£Ü 7,310,000 (ºÎ°¡¼¼ º°µµ)
|
¼¼°èÀÇ ³¼Ò¾Ï Ä¡·áÁ¦ ½ÃÀå
Ovarian Cancer Drugs
¹ßÇà 2024³â 08¿ù
°¡°Ý
US $ 5,450
£Ü 7,310,000 (ºÎ°¡¼¼ º°µµ)
|
¼¼°èÀÇ ½Å°æ¾Æ¼¼Æ÷Á¾ Ä¡·áÁ¦ ½ÃÀå
Neuroblastoma Drugs
¹ßÇà 2024³â 08¿ù
°¡°Ý
US $ 5,450
£Ü 7,310,000 (ºÎ°¡¼¼ º°µµ)
|
¼¼°èÀÇ Àν¶¸°Á¾ Ä¡·á ½ÃÀå
Insulinoma Treatment
¹ßÇà 2024³â 08¿ù
°¡°Ý
US $ 5,450
£Ü 7,310,000 (ºÎ°¡¼¼ º°µµ)
|
¼¼°èÀÇ È£ÁöŲ½º ¸²ÇÁÁ¾ Ä¡·á ½ÃÀå
Hodgkins Lymphoma Treatment
¹ßÇà 2024³â 08¿ù
°¡°Ý
US $ 5,600
£Ü 7,511,000 (ºÎ°¡¼¼ º°µµ)
|
¼¼°èÀÇ HER2 À½¼º À¯¹æ¾Ï ½ÃÀå
HER2 - Negative Breast Cancer
¹ßÇà 2024³â 08¿ù
°¡°Ý
US $ 5,600
£Ü 7,511,000 (ºÎ°¡¼¼ º°µµ)
|
¼¼°èÀÇ ½Äµµ¾Ï Ä¡·áÁ¦ ½ÃÀå
Esophageal Cancer Drugs
¹ßÇà 2024³â 08¿ù
°¡°Ý
US $ 5,600
£Ü 7,511,000 (ºÎ°¡¼¼ º°µµ)
|
¼¼°èÀÇ Ç÷¾×¾Ï Ä¡·áÁ¦ ½ÃÀå
Blood Cancer Therapeutics
¹ßÇà 2024³â 08¿ù
°¡°Ý
US $ 5,600
£Ü 7,511,000 (ºÎ°¡¼¼ º°µµ)
|
¼¼°èÀÇ ¾Ï ¹é½Å ½ÃÀå
Cancer Vaccines
¹ßÇà 2024³â 08¿ù
°¡°Ý
US $ 5,600
£Ü 7,511,000 (ºÎ°¡¼¼ º°µµ)
|